← Search & browse all drugs
ANTIINFECTIVES FOR SYSTEMIC USE › VACCINES › VIRAL VACCINES › Influenza vaccines
influenza, inactivated, whole virus
J07BB01
Forms & Strengths
- 0.5ml prefilled syringe
- 5ml multidose vial
- 0.25ml prefilled syringe for pediatric use
Adult Dosing
- 0.5ml intramuscularly once a year
- Dose may vary based on patient population and vaccine formulation
Pediatric Dosing
- 0.25ml intramuscularly for children 6-35 months
- 0.5ml intramuscularly for children 3 years and older
- two doses at least 4 weeks apart for children 6 months to 8 years who are receiving influenza vaccine for the first time
Indications
- Prevention of influenza in individuals 6 months and older
- Annual vaccination recommended
Mechanism of Action
- Stimulates the immune system to produce antibodies against influenza virus
- Activates cell-mediated immune response
Contraindications
- Hypersensitivity to eggs or any component of the vaccine
- Severe allergic reaction to previous influenza vaccine
- Guillain-Barré Syndrome within 6 weeks of receipt of a prior influenza vaccine
Adverse Reactions
- Pain, redness, or swelling at injection site
- Fever, chills, or muscle aches
- Fatigue, headache, or nausea
Drug Interactions
- Concomitant use with immunosuppressants may reduce vaccine efficacy
- May interfere with tuberculin skin test results for up to 4-6 weeks
Curated Content: Needs Vetting Before Put to Clinical Use